Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. EPS 2020–2025
Aldeyra Therapeutics Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Aldeyra Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.06, a 64.71% decrease year-over-year.
- Aldeyra Therapeutics Inc. annual eps for 2025 was $0.56, a 40.43% decrease from 2024.
- Aldeyra Therapeutics Inc. annual eps for 2024 was $0.94, a 46.87% increase from 2023.
- Aldeyra Therapeutics Inc. annual eps for 2023 was $0.64, a 39.62% decrease from 2022.
- Aldeyra Therapeutics Inc. annual eps for 2022 was $1.06.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Aldeyra Therapeutics Inc. EPS — FAQ
Aldeyra Therapeutics Inc. (ALDX) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Aldeyra Therapeutics Inc.'s eps?
Aldeyra Therapeutics Inc. (ALDX) reported eps of $-0.56 for fiscal 2025.
Where can I see ALDX's eps history?
The chart and table above show Aldeyra Therapeutics Inc.'s eps by year and by quarter, including the growth rate.